These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 25307511

  • 1. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C, Tarnow L, Goetze JP, Rossing P.
    Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
    [Abstract] [Full Text] [Related]

  • 2. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
    Nielsen SE, Persson F, Frandsen E, Sugaya T, Hess G, Zdunek D, Shjoedt KJ, Parving HH, Rossing P.
    Diabet Med; 2012 Aug; 29(8):e184-90. PubMed ID: 22268920
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).
    Rutter MK, Prais HR, Charlton-Menys V, Gittins M, Roberts C, Davies RR, Moorhouse A, Jinadev P, France M, Wiles PG, Gibson JM, Dean J, Kalra PA, Cruickshank JK, Durrington PN.
    Diabet Med; 2011 Jan; 28(1):100-8. PubMed ID: 21166851
    [Abstract] [Full Text] [Related]

  • 5. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.
    Ranganathan S, Krempf M, Feraille E, Charbonnel B.
    Diabete Metab; 1993 Jan; 19(2):257-61. PubMed ID: 8339858
    [Abstract] [Full Text] [Related]

  • 6. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
    Andrésdóttir G, Bakker SJ, Hansen HP, Parving HH, Rossing P.
    Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
    [Abstract] [Full Text] [Related]

  • 7. Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy.
    Mathiesen ER, Hommel E, Olsen UB, Parving HH.
    Diabet Med; 1988 Mar; 5(2):145-9. PubMed ID: 2964980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.
    de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D.
    Lancet; 2010 Nov 06; 376(9752):1543-51. PubMed ID: 21055801
    [Abstract] [Full Text] [Related]

  • 12. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.
    Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, Kong J, Shi H, Chang A, Li YC.
    Kidney Int; 2010 Jun 06; 77(11):1000-9. PubMed ID: 20182412
    [Abstract] [Full Text] [Related]

  • 13. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L, Janicke I, Bender R, Berger M, Sawicki PT.
    Horm Metab Res; 1996 Oct 06; 28(10):549-52. PubMed ID: 8934214
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T, Tamura K, Moriya T, Tanaka K, Konno Y, Kondoh S, Toyoda M, Umezono T, Fujikawa T, Ohsawa M, Dejima T, Maeda A, Wakui H, Haku S, Yanagi M, Mitsuhashi H, Ozawa M, Okano Y, Ogawa N, Yamakawa T, Mizushima S, Suzuki D, Umemura S.
    Clin Exp Hypertens; 2011 Oct 06; 33(4):255-63. PubMed ID: 21699452
    [Abstract] [Full Text] [Related]

  • 17. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.
    Am J Kidney Dis; 2012 Jan 06; 59(1):75-83. PubMed ID: 22051245
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial.
    Taheri S, Asim M, Al Malki H, Fituri O, Suthanthiran M, August P, IDEAL-2 Study Team.
    Trials; 2018 Apr 17; 19(1):230. PubMed ID: 29665833
    [Abstract] [Full Text] [Related]

  • 20. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S, Hansen TW, Goetze JP, Rossing P.
    Am J Hypertens; 2015 Jun 17; 28(6):772-9. PubMed ID: 25468806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.